Covaxin Acts Against UK Variant Virus

Bharat Biotech's indigenously produced COVID-19 vaccine Covaxin acts against the new B.1.1.7 variant of SARS-CoV-2, said Balrama Bhargava, DG ICMR. The National Institute of Virology, Pune under the aegis of the Indian Council of Medical Research isolated the British variant and tested the vaccine against the strain.